Trimerization of CD40L-specific affibody molecules using collagen domains enhances target binding and CD40 blockade.
Saved in:
| Title: | Trimerization of CD40L-specific affibody molecules using collagen domains enhances target binding and CD40 blockade. |
|---|---|
| Authors: | Westerberg C; Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Stockholm, 106 91, Sweden., Sorini C; Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, 171 76, Sweden., Al-Haddad M; Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Stockholm, 106 91, Sweden., Mehari H; Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Stockholm, 106 91, Sweden., Ståhl S; Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Stockholm, 106 91, Sweden., Jagodic M; Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, 171 76, Sweden., Löfblom J; Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Stockholm, 106 91, Sweden. lofblom@kth.se. |
| Source: | Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2026 Jun 24; Vol. 83 (1). Date of Electronic Publication: 2026 Jun 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: Switzerland NLM ID: 9705402 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-9071 (Electronic) Linking ISSN: 1420682X NLM ISO Abbreviation: Cell Mol Life Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42340401 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Trimerization of CD40L-specific affibody molecules using collagen domains enhances target binding and CD40 blockade. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Westerberg+C%22">Westerberg C</searchLink>; Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Stockholm, 106 91, Sweden.<br /><searchLink fieldCode="AU" term="%22Sorini+C%22">Sorini C</searchLink>; Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, 171 76, Sweden.<br /><searchLink fieldCode="AU" term="%22Al-Haddad+M%22">Al-Haddad M</searchLink>; Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Stockholm, 106 91, Sweden.<br /><searchLink fieldCode="AU" term="%22Mehari+H%22">Mehari H</searchLink>; Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Stockholm, 106 91, Sweden.<br /><searchLink fieldCode="AU" term="%22Ståhl+S%22">Ståhl S</searchLink>; Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Stockholm, 106 91, Sweden.<br /><searchLink fieldCode="AU" term="%22Jagodic+M%22">Jagodic M</searchLink>; Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, 171 76, Sweden.<br /><searchLink fieldCode="AU" term="%22Löfblom+J%22">Löfblom J</searchLink>; Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Stockholm, 106 91, Sweden. lofblom@kth.se. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229705402%22">Cellular and molecular life sciences : CMLS</searchLink> [Cell Mol Life Sci] 2026 Jun 24; Vol. 83 (1). <i>Date of Electronic Publication: </i>2026 Jun 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>9705402 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1420-9071 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221420682X%22">1420682X </searchLink><i>NLM ISO Abbreviation: </i>Cell Mol Life Sci <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42340401 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00018-026-06301-2 Languages: – Code: eng Text: English Titles: – TitleFull: Trimerization of CD40L-specific affibody molecules using collagen domains enhances target binding and CD40 blockade. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Westerberg C – PersonEntity: Name: NameFull: Sorini C – PersonEntity: Name: NameFull: Al-Haddad M – PersonEntity: Name: NameFull: Mehari H – PersonEntity: Name: NameFull: Ståhl S – PersonEntity: Name: NameFull: Jagodic M – PersonEntity: Name: NameFull: Löfblom J IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 06 Text: 2026 Jun 24 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1420-9071 Numbering: – Type: volume Value: 83 – Type: issue Value: 1 Titles: – TitleFull: Cellular and molecular life sciences : CMLS Type: main |
| ResultId | 1 |
